P2RX7 and Alzheimer disease: Interestingly, the simultaneous downregulation of integrins and P2X7 was demonstrated, indicating that the pre-clinical AD patients expressed both low levels of P2X7 and integrins on their monocytes and neutrophils, which stayed low throughout disease course.